Role of angiotensin receptor-neprilysin inhibitor in diabetic complications
World Journal of Diabetes · 15.05.2024 · 15 (5) · 867-875
DOI: 10.4239/wjd.v15.i5.867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Journal of Diabetes, online erschienen am 15.05.2024. Verfasst von Ying Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Second Hospi…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
- Department of Cardiology, Xuzhou No. 1 Peoples Hospital, Xuzhou 221005, Jiangsu Province, China.
- Department of Cardiology, Wuxi 9 People's Hospital Affiliated to Soochow University, Wuxi 214062, Jiangsu Province, China.
- Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, Jiangsu Province, China.
- School of Nursing and Health Studies, Metropolitan University, Hong Kong 999077, China.
- Kent and Medway Medical School, Kent CT2 7NT, Canterbury, United Kingdom.
Zitieren
APA
Liu, Y., Lu, C. Y., Zheng, Y., Zhang, Y. M., Qian, L. L., Li, K. L., Tse, G., Wang, R. X., & Liu, T. (2024). Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World Journal of Diabetes, 15(5), 867-875. https://doi.org/10.4239/wjd.v15.i5.867
Vancouver
Liu Y, Lu CY, Zheng Y, Zhang YM, Qian LL, Li KL, et al. Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World Journal of Diabetes. 2024;15(5):867-875. doi:10.4239/wjd.v15.i5.867
BibTeX
@article{Liu2024,
author = {Liu, Ying and Lu, Cun-Yu and Zheng, Yi and Zhang, Yu-Min and Qian, Ling-Ling and Li, Ku-Lin and Tse, Gary and Wang, Ru-Xing and Liu, Tong},
title = {Role of angiotensin receptor-neprilysin inhibitor in diabetic complications},
journal = {World Journal of Diabetes},
year = {2024},
volume = {15},
number = {5},
pages = {867--875},
doi = {10.4239/wjd.v15.i5.867}
}
EUVIMED